Featured Research

from universities, journals, and other organizations

Toward A Noninvasive Diagnostic Test For Serious Infections In Pregnancy

Date:
December 12, 2006
Source:
American Chemical Society
Summary:
Scientists have discovered the basis for a noninvasive test to diagnose common infections in pregnant women that are a major cause of premature births and infant deaths. The University of Washington's Michael G. Gravett and colleagues are reporting identification of protein biomarkers for these hard-to-diagnose infections of the amniotic fluid, which surrounds the fetus prior to birth.

Scientists have discovered the basis for a noninvasive test to diagnose common infections in pregnant women that are a major cause of premature births and infant deaths. The University of Washington's Michael G. Gravett and colleagues are reporting identification of protein biomarkers for these hard-to-diagnose infections of the amniotic fluid, which surrounds the fetus prior to birth.

Prematurity complicates 12.5 percent of all births, causing an estimated 400,000 preterm births annually in the United States, and involves health care costs in excess of $26 billion annually. Intra-amniotic infection (IAI) is an important and potentially preventable cause of preterm birth, responsible for one-half of extremely preterm births and very low birth-weight babies.

In the study, reported in the Jan. 5 issue of the monthly ACS Journal of Proteome Research, scientists describe identifying protein biomarkers for those infections in the cervical and vaginal fluid of rhesus monkeys. The discovery, they state, "provides an opportunity for development of noninvasive reliable tests for the diagnosis of IAI."

Such tests, they indicate, could diagnose IAI earlier and more accurately than existing diagnostic methods. Those methods include blood tests and amniocentesis, in which a needle is used to take amniotic fluid through the abdominal wall.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "Toward A Noninvasive Diagnostic Test For Serious Infections In Pregnancy." ScienceDaily. ScienceDaily, 12 December 2006. <www.sciencedaily.com/releases/2006/12/061211115201.htm>.
American Chemical Society. (2006, December 12). Toward A Noninvasive Diagnostic Test For Serious Infections In Pregnancy. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2006/12/061211115201.htm
American Chemical Society. "Toward A Noninvasive Diagnostic Test For Serious Infections In Pregnancy." ScienceDaily. www.sciencedaily.com/releases/2006/12/061211115201.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins